Advertisements



Amgen"s Repatha "significantly reduced" LDL-C, non-HDL-C in Type 2 diabetes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 23rd, 2018

Amgen"s Repatha Reduces Bad Cholestrol in Type II Diabetes

Amgen's (AMGN) Repatha signi.....»»

Category: smallbizSource: nytJun 25th, 2018

Amgen makes all Repatha device options available in U.S. at 60% reduced price

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 7th, 2019

Amgen makes Repatha available in U.S. at 60% reduced price

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 24th, 2018

Tuberculosis Vaccine Could Reverse Type 1 Diabetes, Study Shows

Just two jabs reverses diabetes even in people who have had the Type 1 form for decades. The causes of Type 1 diabetes can be significantly reversed over several years with just two injections of a common .....»»

Category: europeSource: fortuneJun 21st, 2018

Amgen announces new 4-yr outcomes study to examine long-term effects of repatha

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 15th, 2019

23andMe eyes millions of more users with new report on diabetes

23andMe is adding a report to its health and ancestry DNA test for type 2 diabetes. That's a huge market opportunity as 1 in 3 people are at risk for developing the disease. More than 30 million people in the U.S. alone have diabetes......»»

Category: topSource: moneycentralMar 10th, 2019

Amgen patents for cholesterol drug Repatha upheld by jury

A U.S. jury upheld two patents for Amgen Inc.’s cholesterol-lowering drug Repatha, dealing a blow to Sanofi and Regeneron Pharmaceuticals Inc., which make a similar medication called Praluent......»»

Category: topSource: moneycentralFeb 25th, 2019

Delaware jury upholds Amgen"s patents on Repatha

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 25th, 2019

Amgen Starts Phase III Enrollment for Heart Failure Drug

Amgen (AMGN) and partners started enrollment for the second phase III study of omecamtiv mecarbil, which is being developed for the potential treatment of heart failure with reduced ejection fra.....»»

Category: worldSource: nytFeb 22nd, 2019

The Wall Street Journal: OPEC daily production falls by about 800,000 barrels, according to monthly report

OPEC significantly reduced its crude-oil production in January, making good on its latest deal to curb output and rebalance an oversupplied market, the oil cartel said Tuesday......»»

Category: topSource: marketwatchFeb 12th, 2019

Amgen reports Q4 Repatha sales up 62%, Neulasta up 5%

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 29th, 2019

Pesticide Levels In Children And Adults Drop Dramatically After One Week Of Eating Organic

WASHINGTON, D.C. – A groundbreaking peer-reviewed study published today in the journal Environmental Research found that switching to an organic diet significantly reduced th.....»»

Category: blogSource: valuewalkJan 28th, 2019

Amgen receives NMPA approval for Repatha in China

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 24th, 2019

FDA Diabetes Treatment Vote to Determine the Fate of Lexicon Therapeutics?

Lexicon shares fell on Friday after the FDA voted to approve the firm’s type 1 diabetes treatment. Although the result from this committee was mixed, it seems to be a case of sell the news......»»

Category: blogSource: 247wallstJan 18th, 2019

Lexicon Pharmaceuticals stock to be halted Thursday as FDA committee reviews diabetes treatment

Lexicon Pharmaceuticals Inc. stock will be halted from trading Thursday, as a U.S. Food and Drug Administration committee reviews a treatment for adults with type 1 diabetes. The company said the co.....»»

Category: topSource: marketwatchJan 17th, 2019

Mexico Reduces U.S. Gasoline Imports

Mexico has significantly reduced imports of U.S. gasoline since President Andrés Manuel López Obrador took office Dec. 1, as a government crackdown on fuel theft has jammed up distribution and caused widespread gasoline shortages......»»

Category: topSource: wsjJan 12th, 2019

Amgen Reduces Price of Repatha Devices

Stock rises following announcementRelated Stocks: AMGN,.....»»

Category: blogSource: gurufocusJan 8th, 2019

Amgen cuts price of Repatha by 60% due to patients struggling to pay, CNBC says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 8th, 2019

Amgen Set For 2019 With Aimovig, Repatha, And Rest Of Pipeline

Amgen Set For 2019 With Aimovig, Repatha, And Rest Of Pipeline.....»»

Category: topSource: seekingalphaDec 20th, 2018

Eli Lilly partners with DCRI for type 2 Diabetes care study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 13th, 2018